Related Experiment Video
Updated: Jul 8, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Dopamine-beta hydroxylase polymorphism and cocaine addiction.
Camila Guindalini1, Ronaldo Laranjeira, David Collier
1MRC Social Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, King's College London, UK. g.breen@iop.kcl.ac.uk.
Behavioral and Brain Functions : BBF
|January 5, 2008
Summary
The -1021C>T polymorphism in the dopamine-beta hydroxylase (DbH) gene does not appear to influence cocaine addiction susceptibility. Further research into other genetic variants is needed to fully understand the gene's role.
Area of Science:
- Neuroscience
- Genetics
- Addiction Research
Background:
- Cocaine addiction presents complex medical, psychological, and social challenges.
- Understanding the genetic basis of cocaine addiction is crucial for developing effective treatments.
- Dopamine-beta hydroxylase (DbH) enzyme activity, influenced by the -1021C>T polymorphism, may affect neurotransmitter systems and cocaine's impact.
Purpose of the Study:
- To investigate the association between the -1021C>T polymorphism in the DbH gene and susceptibility to cocaine addiction.
- To determine if this specific genetic variation plays a significant role in the development of cocaine use disorder.
Main Methods:
- Genotyping of the -1021C>T polymorphism in 689 individuals with cocaine addiction and 832 healthy controls.
- Statistical analyses including genotypic and allelic comparisons.
- Correction for population stratification and other potential confounding factors.
Main Results:
- No significant evidence of association was found between the -1021C>T polymorphism and cocaine addiction.
- Allelic and genotypic analyses did not support a role for this polymorphism in addiction susceptibility.
- Results remained non-significant after adjusting for confounders.
Conclusions:
- The -1021C>T polymorphism in the DbH gene is unlikely to be a major factor in the development of cocaine addiction.
- The study does not support a significant role for the DbH gene in cocaine addiction.
- Further investigation of other genetic variants within the DbH gene is warranted to definitively exclude its involvement.
Related Concept Videos
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...